Literature DB >> 25975966

Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline.

Finnian R Mc Causland1, Sushrut S Waikar2.   

Abstract

BACKGROUND: The rapid reduction in plasma osmolality during hemodialysis (HD) may induce temporary gradients that promote the movement of water from the extracellular to the intracellular compartment, predisposing to the development of intradialytic hypotension (IDH). STUDY
DESIGN: Observational cohort study. SETTING &amp; PARTICIPANTS: 3,142 prevalent patients receiving thrice-weekly HD from a single dialysis provider organization. PREDICTOR: Predialysis calculated plasma osmolarity (calculated after the 2-day interval as 2 × serum sodium + serum urea nitrogen/2.8 + serum glucose/18). OUTCOME: Magnitude of systolic blood pressure (SBP) decline (predialysis SBP - nadir intradialytic SBP) and risk of IDH (SBP decline > 35 or nadir SBP < 90 mm Hg). MEASUREMENTS: Unadjusted and multivariable-adjusted generalized linear models were fit to estimate the association of calculated osmolarity with intradialytic SBP decline and the odds of developing IDH.
RESULTS: Mean age of participants was 62.6±15.2 (SD) years, 57.1% were men, and 61.0% had diabetes. Mean predialysis calculated osmolarity during follow-up was 306.4 ± 9.5 mOsm/L. After case-mix adjustment, each 10-mOsm/L increase in predialysis calculated osmolarity was associated with 1.48 (95% CI, 0.86-2.09) mm Hg (P < 0.001) greater decline in intradialytic SBP and 10% greater odds of IDH (OR, 1.10; 95% CI, 1.05-1.15). In adjusted models, lower predialysis sodium and higher serum urea nitrogen and serum glucose levels were associated with greater decline in intradialytic SBP. LIMITATIONS: Measured serum osmolality, timing of changes in intradialytic osmolality, dialysate osmolality, and dialysate temperature were not available.
CONCLUSIONS: Higher predialysis calculated osmolarity is associated with greater decline in intradialytic SBP and greater risk of IDH in maintenance HD patients. Strategies to minimize rapid shifts in osmolality should be tested prospectively to minimize excess SBP decline in susceptible patients.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intra-dialytic hypotension; calculated plasma osmolarity; end-stage renal disease (ESRD); hemodialysis; hemodynamic instability; osmolality; renal replacement therapy (RRT); systolic blood pressure (SBP)

Mesh:

Year:  2015        PMID: 25975966      PMCID: PMC4782777          DOI: 10.1053/j.ajkd.2015.03.028

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  45 in total

1.  Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients.

Authors:  Tatsuya Shoji; Yoshiharu Tsubakihara; Masamitsu Fujii; Enyu Imai
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

2.  Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension.

Authors:  E S Kersh; S J Kronfield; A Unger; R W Popper; S Cantor; K Cohn
Journal:  N Engl J Med       Date:  1974-03-21       Impact factor: 91.245

3.  Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate.

Authors:  F K Port; W J Johnson; D W Klass
Journal:  Kidney Int       Date:  1973-05       Impact factor: 10.612

4.  Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis.

Authors:  A I Arieff; S G Massry; A Barrientos; C R Kleeman
Journal:  Kidney Int       Date:  1973-09       Impact factor: 10.612

5.  Importance of the plasma refilling rate in the genesis of hypovolaemic hypotension during regular dialysis and controlled sequential ultrafiltration-haemodialysis.

Authors:  J J Rouby; J Rottembourg; J P Durande; J Y Basset; M Legrain
Journal:  Proc Eur Dial Transplant Assoc       Date:  1978

6.  Significance of interdialytic weight gain versus chronic volume overload: consensus opinion.

Authors:  Manfred Hecking; Angelo Karaboyas; Marlies Antlanger; Rajiv Saran; Volker Wizemann; Charles Chazot; Hugh Rayner; Walter H Hörl; Ronald L Pisoni; Bruce M Robinson; Gere Sunder-Plassmann; Ulrich Moissl; Peter Kotanko; Nathan W Levin; Marcus D Säemann; Kamyar Kalantar-Zadeh; Friedrich K Port; Peter Wabel
Journal:  Am J Nephrol       Date:  2013-07-06       Impact factor: 3.754

7.  The effects of rapid hemodialysis on brain tissues and cerebrospinal fluid of dogs.

Authors:  H M Pappius; J H Oh; J B Dossetor
Journal:  Can J Physiol Pharmacol       Date:  1967-01       Impact factor: 2.273

8.  Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: a 3-year prospective study.

Authors:  Tohru Mizumasa; Hideki Hirakata; Takahiro Yoshimitsu; Eriko Hirakata; Michiaki Kubo; Minoru Kashiwagi; Hiroshi Tanaka; Hidetoshi Kanai; Satoru Fujimi; Mitsuo Iida
Journal:  Nephron Clin Pract       Date:  2004

9.  Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis.

Authors:  T Fasanella d'Amore; J P Wauters; B Waeber; J Nussberger; H R Brunner
Journal:  Clin Nephrol       Date:  1985-06       Impact factor: 0.975

10.  Role of osmolality in blood pressure stability after dialysis and ultrafiltration.

Authors:  W L Henrich; T D Woodard; J D Blachley; C Gomez-Sanchez; W Pettinger; R E Cronin
Journal:  Kidney Int       Date:  1980-10       Impact factor: 10.612

View more
  14 in total

1.  Sodium removal and plasma tonicity balance are not different in hemodialysis and hemodiafiltration using high-flux membranes.

Authors:  Vincenzo La Milia; Chiara Ravasi; Fabio Carfagna; Elena Alberghini; Ivano Baragetti; Laura Buzzi; Francesca Ferrario; Silvia Furiani; Gaia Santagostino Barbone; Giuseppe Pontoriero
Journal:  J Nephrol       Date:  2019-01-10       Impact factor: 3.902

2.  Real-time Noninvasive Monitoring of Intracranial Fluid Shifts During Dialysis Using Volumetric Integral Phase-Shift Spectroscopy (VIPS): A Proof-of-Concept Study.

Authors:  Chethan P Venkatasubba Rao; Eric M Bershad; Eusebia Calvillo; Nelson Maldonado; Rahul Damani; Sreedhar Mandayam; Jose I Suarez
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

Review 3.  Dialysate Sodium: Rationale for Evolution over Time.

Authors:  Jennifer E Flythe; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

4.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

Review 5.  Osmolality and blood pressure stability during hemodialysis.

Authors:  Anika T Singh; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-07-09       Impact factor: 3.455

6.  Definitions of intradialytic hypotension.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Semin Dial       Date:  2017-07-09       Impact factor: 3.455

7.  Hypertonic Mannitol for the Prevention of Intradialytic Hypotension: A Randomized Controlled Trial.

Authors:  Finnian R Mc Causland; Brian Claggett; Venkata S Sabbisetti; Petr Jarolim; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2019-04-27       Impact factor: 8.860

Review 8.  Pathophysiology and implications of intradialytic hypertension.

Authors:  Peter Noel Van Buren
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-07       Impact factor: 2.894

Review 9.  Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension.

Authors:  Patrick B Reeves; Finnian R Mc Causland
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-26       Impact factor: 8.237

10.  Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis.

Authors:  Yasushi Tsujimoto; Hiraku Tsujimoto; Yukihiko Nakata; Yuki Kataoka; Miho Kimachi; Sayaka Shimizu; Tatsuyoshi Ikenoue; Shingo Fukuma; Yosuke Yamamoto; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.